Abstract:Background Extended criteria donors (ECD) are widely utilized due to organ shortage, but they may increase the risk of graft dysfunction and poorer outcomes. Hypothermic oxygenated perfusion (HOPE) is a recent organ preservation strategy for marginal kidney and liver grafts, allowing a redirect from anaerobic metabolism to aerobic metabolism under hypothermic conditions and protecting grafts from oxidative species–related damage. These mechanisms may improve graft function and survival. Objective With this study, we will evaluate the benefit of end-ischemic HOPE on ECD grafts for livers and kidneys as compared to static cold storage (SCS). The aim of the study is to demonstrate the ability of HOPE to improve graft function and postoperative outcomes of ECD kidney and liver recipients. Methods This is an open-label, single-center randomized clinical trial with the aim of comparing HOPE with SCS in ECD kidney and liver transplantation. In the study protocol, which has been approved by the ethics committee, 220 patients (110 liver recipients and 110 kidney recipients) will be enrolled. Livers and kidneys assigned to the HOPE group undergo machine perfusion with cold Belzer solution (4-10°C) and continuous oxygenation (partial pressure of oxygen of 500-600 mm Hg). In the control group, livers and kidneys undergoing SCS are steeped in Celsior solution and stored on ice. Using the same perfusion machine for both liver and kidney grafts, organs are perfused from the start of the back-table procedure until implantation, without increasing the cold ischemia time. For each group, we will evaluate clinical outcomes, graft function tests, histologic findings, perfusate, and the number of allocated organs. Publication of the results is expected to begin in 2021. Results Dynamic preservation methods for organs from high-risk donors should improve graft dysfunction after transplantation. To date, we have recruited 108 participants. The study is ongoing, and recruitment of participants will continue until January 2020. Conclusions The proposed preservation method should improve ECD graft function and consequently the postoperative patient outcomes. Trial Registration ClinicalTrials.gov NCT03837197; https://clinicaltrials.gov/ct2/show/NCT03837197 ; Archived by WebCite® at http://www.webcitation.org/76fSutT3R International Registered Report Identifier (IRRID) DERR1-10.2196/13922

Static lung storage at 10°C maintains mitochondrial health and preserves donor organ function

The Advent of Semi-Elective Lung Transplantation—Prolonged Static Cold Storage at 10°C

Protective effects of 10°C preservation on donor lungs with lipopolysaccharide-induced acute lung injury

Donor Lung Preservation at 10°C: Clinical and Logistical Impact

Successful 3-day lung preservation using a cyclic normothermic ex vivo lung perfusion strategy

Metabolomic studies reveal an organ-protective hibernation state in donor lungs preserved at 10°C

Evaluation of 10°C as the Optimal Storage Temperature for Aspiration-Injured Donor Lungs in a Large Animal Transplant Model

Devices for donor lung preservation

Activation of Mitochondrial Atp-Sensitive Potassium Channel Contributes to Protective Effect in Prolonged Myocardial Preservation

Overview of novel donor lung preservation system mediating stable organ temperature and airway pressure

Controlled Hypothermic Storage for Lung Preservation: Leaving the Ice Age Behind

Extended Ischemic Time (> 15 Hours) Using Controlled Hypothermic Storage in Lung Transplantation: A Multicenter Experience

Oxygenated machine perfusion at room temperature as an alternative for static cold storage in porcine donor hearts

The dynamic progress of cell death during donor lung preservation

Optimized partial freezing protocol enables 10-day storage of rat livers

Ex vivo lung perfusion with perfusate purification for human donor lungs following prolonged cold storage

Novel vs clinical organ preservation solutions: improved cardiac mitochondrial protection

Lung transplantation following controlled hypothermic storage with a portable lung preservation device: first multicenter European experience

Effect of Ex Vivo Lung Perfusion on Storage of Isolated Lungs.

Inflation using hydrogen improves donor lung quality by regulating mitochondrial function during cold ischemia phase

Hypothermic Oxygenated Perfusion Versus Static Cold Storage for Expanded Criteria Donors in Liver and Kidney Transplantation: Protocol for a Single-Center Randomized Controlled Trial